Stryker Corporation
Stryker Reports 20.0% EPS Increase in Q3 2024
Summary
Stryker Corporation reported a 20.0% increase in Earnings Per Share (EPS) to $2.16 for the third quarter of 2024. The company's net sales rose by 11.9% to $5.5 billion, with organic net sales growing by 11.5%. Adjusted operating income margin increased to 24.7%. Stryker also provided an outlook for full-year 2024, expecting organic net sales growth in the range of 9.5% to 10.0%. A press release with detailed financial results is attached as Exhibit 99.1.
Profitelligence Alerts
Get alerts for SYK
Be first to know when Stryker Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Stryker Corporation
Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.
Official SEC Documents
Advertisement